Immunotherapy for Metastatic Breast Cancer

Immunotherapy works with the body’s immune system to find, attack, and kill cancer cells. These drugs can work in different ways. Some boost the immune system, so it can fight cancer better. Other immunotherapy drugs help the immune system better recognize cancer cells. 

This is the latest type of immunotherapy to treat metastatic breast cancer. 

Please note: The side effects listed here do not represent a comprehensive list. It's important to discuss all potential side effects of a drug with your healthcare team. Be sure to tell your healthcare team about any side effects you do have.

Treatment Type

Checkpoint Inhibitor

Drug Name
Tecentriq® (atezolizumab)
Potential Side Effects - Abraxane
Constipation Hair thinning/loss Low blood counts Neuropathy
Important Things to Know
  • This treatment is for triple-negative breast cancer (TNBC) that is PD-L1 positive.
  • This treatment is given with Abraxane® (chemotherapy drug).
  • This is the first immunotherapy regimen approved for breast cancer.
  • Low white and red blood cell counts are a potential side effect of Abraxane. Low blood counts may put you at risk for for anemia, infection, fatigue, or bleeding.